LOGIN  |  REGISTER
Viking Therapeutics

Recent Insider Transactions - Centene (NYSE: CNC)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NYSE CNC Centene
Asher Andrew Lynn / officer: Chief Financial Officer
11/13/2024
Buy
$58.14
17,200
$1.000M
486,847
NYSE CNC Centene
LONDON SARAH / director, officer: Chief Executive Officer
11/08/2024
Buy
$60.80
4,117
$250K
667,229

COPYRIGHT ©2023 HEALTH STOCKS HUB